Polymorphism in hydroxylation of mephenytoin and hexobarbital stereoisomers in relation to hepatic P-450 human-2
- 1 March 1990
- journal article
- research article
- Published by Springer Nature in Clinical Pharmacology & Therapeutics
- Vol. 47 (3) , 313-322
- https://doi.org/10.1038/clpt.1990.34
Abstract
Stereoselective 4′‐hydroxylations of R‐(−)‐mephenytoin and S‐(+)‐mephenytoin and 3′‐hydroxylation of R‐(‐)‐hexobarbital and S‐(+)‐hexobarbital were determined in liver microsomes of 14 Japanese subjects who were extensive metabolizers of mephenytoin and in five Japanese subjects who were poor metabolizers of mephenytoin. Content of P‐450 human‐2 assessed by Western blots was correlated to microsomal S‐(+)‐mephenytoin 4′‐hydroxylation, R‐(−)‐hexobarbital 3′ α‐hydroxylation, and S‐(+)‐hexobarbital 3′ ß‐hydroxylation, and was less correlated to R‐(−)‐mephenytoin 4′‐hydroxylation, R‐(−)‐hexobarbital 3′ ß‐hydroxylation, and S‐(+)‐hexobarbital 3′ α‐hydroxylation. Antibodies raised against P‐450 human‐2 inhibited microsomal S‐(+)‐mephenytoin 4′‐hydroxylation efficiently but was less efficient on R‐(−) ‐mephenytoin 4′‐hydroxylation in extensive metabolizers and on 4′‐hydroxylation of mephenytoin enantiomers in poor metabolizers. The antibodies also inhibited R‐(−)‐hexobarbital 3′ α‐hydroxylation and S‐(+)‐hexobarbital 3′ ß‐hydroxylation but did not effectively inhibit the hydroxylation of the two other optical isomers of hexobarbital in extensive metabolizers and of four stereoisomers in poor metabolizers. These findings indicate the close relationship between polymorphic mephenytoin 4′‐hydroxylation and two stereospecific hexobarbital hydroxylations, and they suggest that P‐450 human‐2 is a typical S‐(+)‐mephenytoin 4′‐hydroxylase and a major hexobarbital 3′‐hydroxylase in the livers of extensive metabolizers. The findings were further supported by the experiments that used P‐450 human‐2 complementary dexoyribonucleic acid‐derived protein in yeast microscomes. Clinical Pharmacology and Therapeutics (1990) 47, 313–322; doi:10.1038/clpt.1990.34Keywords
This publication has 25 references indexed in Scilit:
- Stereoselective mephobarbital hydroxylation cosegregates with mephenytoin hydroxylationClinical Pharmacology & Therapeutics, 1985
- Interethnic differences in genetic polymorphism of debrisoquin and mephenytoin hydroxylation between Japanese and Caucasian populationsClinical Pharmacology & Therapeutics, 1985
- Genetic polymorphism of mephenytoin p(4′)‐hydroxylation: difference between Orientals and Caucasians.British Journal of Clinical Pharmacology, 1985
- Mephenytoin hydroxylation deficiency in Caucasians: Frequency of a new oxidative drug metabolism polymorphismClinical Pharmacology & Therapeutics, 1984
- Mephenytoin and sparteine pharmacogenetics in Canadian CaucasiansClinical Pharmacology & Therapeutics, 1984
- Pharmacogenetics of mephenytoin: A new drug hydroxylation polymorphism in manEuropean Journal of Clinical Pharmacology, 1984
- STEREOSELECTIVE METABOLISM AND DISPOSITION OF THE ENANTIOMERS OF MEPHENYTOIN DURING CHRONIC ORAL-ADMINISTRATION OF THE RACEMIC DRUG IN MAN1982
- Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.Proceedings of the National Academy of Sciences, 1979
- The Carbon Monoxide-binding Pigment of Liver MicrosomesJournal of Biological Chemistry, 1964
- PROTEIN MEASUREMENT WITH THE FOLIN PHENOL REAGENTJournal of Biological Chemistry, 1951